Mike Doustdar

Mike Doustdar, the CEO of Novo Nordisk, criticized the Wegovy pill copy from Hims and Hers as a waste of money.

Politiken·Denmark· 2026-02-06

Mike Doustdar explains the challenges Novo Nordisk faces in increasing revenue due to market competition and pricing pressures.

Politiken·Denmark· 2026-02-04

Mike Doustdar, the CEO of Novo Nordisk, explained that the forecast is a result of the company lowering prices on its products significantly.

Politiken·Denmark· 2026-02-04

Mike Doustdar explains the challenges Novo Nordisk faces in increasing revenue due to market competition and pricing pressures.

Politiken·Denmark· 2026-02-04

Mike Doustdar, the CEO of Novo Nordisk, explained that the forecast is a result of the company significantly lowering prices on its products.

Politiken·Denmark· 2026-02-04

Chief executive Mike Doustdar said in a statement that Novo Nordisk will face pricing headwinds in an increasingly competitive market.

The Sydney Morning Herald·Australia· 2026-02-04

Mike Doustdar is the CEO of Novo Nordisk and acknowledges the challenges the company faces in 2026.

Politiken·Denmark· 2026-02-04

Mike Doustdar, the CEO of Novo Nordisk, stated that patients will receive a convenient daily tablet that can help lose as much weight as the original Wegovy injection.

Index.hu·Hungary· 2025-12-26

Mike Doustdar, president and CEO of Novo Nordisk, stated that the Wegovy pill can help patients lose as much weight as the original Wegovy injection.

Fox News·United States· 2025-12-24

Mike Doustdar is the president of the pharmaceutical company Novo Nordisk, which announced the approval of a new oral treatment for obesity.

Expresso das Ilhas – Cape Verdean newspaper & portal·Cabo Verde· 2025-12-24

Mike Doustdar, president and CEO of Novo Nordisk, stated that the approval of the Wegovy pill will provide patients with a practical daily option for weight loss.

El Universo – major Ecuadorian daily, est. 1921·Ecuador· 2025-12-23

Mike Doustdar, the CEO of Novo Nordisk, is excited about the FDA approval of the Wegovy pill.

Politiken·Denmark· 2025-12-23

Securing the first weight-loss pill on the market will be critical for Mike Doustdar, who was appointed chief executive of Novo Nordisk this summer.

The Guardian·United Kingdom· 2025-11-25

Mike Doustdar was mentioned as one of the Novo Nordisk representatives present during the incident.

Hürriyet·Turkey· 2025-11-07

Mike Doustdar emphasized the need for the company to develop a 'culture based on efficiency' during the announcement of the reorganization.

Delo – major Slovenian daily, est. 1959·Slovenia· 2025-09-10

Mike Doustdar is the CEO of Novo Nordisk who announced upcoming layoffs of 9,000 employees.

Politiken·Denmark· 2025-09-10

Mike Doustdar, who assumed leadership last month, said the overhaul would simplify operations, accelerate decision-making and redirect resources toward growth areas.

The Globe and Mail·Canada· 2025-09-10

Mike Doustdar is the new chief executive of Novo Nordisk who announced the job cuts.

BBC·United Kingdom· 2025-09-10

Mike Doustdar is the CEO of Novo Nordisk and emphasizes the need for a more performance-based culture.

Politiken·Denmark· 2025-09-10

Mike Doustdar, the chief executive of Novo Nordisk, discussed the need for a shift in the company's mindset and approach.

The Guardian·United Kingdom· 2025-09-10

Mike Doustdar was announced as the new CEO of Novo Nordisk.

Politiken·Denmark· 2025-08-28

Mike Doustdar is the new CEO of Novo Nordisk tasked with leading the company out of its crisis.

Neue Zürcher Zeitung·Switzerland· 2025-08-25

Mike Doustdar is set to take over as CEO after Lars Fruergaard Jørgensen.

Politiken·Denmark· 2025-08-06

Mike Doustdar is the new CEO of Novo Nordisk who has a significant task ahead of him.

Politiken·Denmark· 2025-08-04

Mike Doustdar is appointed as the new CEO of Novo Nordisk.

Politiken·Denmark· 2025-07-29